Evidence map›Paper›PMID 27721666›Full record

ArticleCanadian respiratory journal2016

Intermittent Courses of Corticosteroids Also Present a Risk for

Maria L Calero-Bernal, Isabel Martin-Garrido, Mikel Donazar-Ezcurra, Andrew H Limper, Eva M Carmona

Open access · goldAbstract read
In one paragraph

Article in Canadian respiratory journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Post-COVID-19 severeThe Journal of international medical research · 2025
    Review
  4. Epidemiology, Risk Factors, and Prophylaxis Use forOpen forum infectious diseases · 2024
    Article
  5. Risk Factors forJournal of fungi (Basel, Switzerland) · 2023
    Article
  6. Trends in the Epidemiology ofJournal of fungi (Basel, Switzerland) · 2023
    Review
  7. Successful treatment of severeSAGE open medical case reports · 2023
    Article
  8. Interest of a CommercializedJournal of clinical medicine · 2022
    Article
  9. Article
  10. Article
  11. The mycological and molecular study ofIranian journal of microbiology · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Top-ten infections in onco-hematological patients (2015-2017).Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2018
    Review
  16. Article
  17. Review
  18. Open forum infectious diseases · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Maria L Calero-BernalDivision of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Servicio de Medicina Interna, Hospital Universitario Virgen del Rocío, Seville, Spain.
Isabel Martin-GarridoDivision of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Servicio de Medicina Interna, Hospital Quirón San Camilo, Madrid, Spain.
Mikel Donazar-EzcurraDivision of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic, Rochester, MN, USA; Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain.
Andrew H LimperDivision of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Eva M CarmonaDivision of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-9852-8396
Mayo Clinic · US

Funding

Pneumocystis: Macrophage & Epithelial ActivationR01HL062150 · NHLBI · MAYO CLINIC ROCHESTER · PI ANDREW H LIMPER · 1998 to 2026
$9.2M
Modulation of host immune defense by Pneumocystis beta-glucansK08HL112849 · NHLBI · MAYO CLINIC ROCHESTER · PI CARMONA PORQUERA, EVA MARIA · 2013 to 2017
$712k
NHLBI NIH HHS K08 HL112849NHLBI NIH HHS R01 HL062150
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adrenal Cortex HormonesAdultAgedAged, 80 and overAnti-Bacterial AgentsFemaleHumansImmunosuppressive AgentsMaleMiddle AgedMinnesotaPneumonia, PneumocystisRetrospective StudiesTrimethoprim, Sulfamethoxazole Drug CombinationYoung AdultAdrenal Cortex HormonesAnti-Bacterial AgentsImmunosuppressive AgentsTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID27721666
PMCPMC5046011
OpenAlexW2520385242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.